Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy

European Journal of Human Genetics

Volumn 16, Issue 10, 2008, Pages 1201-1207

  Christiaans, Imke ^a   Birnie, Erwin ^b   Bonsel, Gouke J ^b   Wilde, Arthur A M ^a   van Langen, Irene M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN BINDING PROTEIN C;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FAMILY ATTITUDE; FAMILY HISTORY; FAMILY STUDY; FEMALE; FIRST DEGREE RELATIVE; GENDER; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE DNA TESTING; PRIORITY JOURNAL; RELATIVE; SARCOMERE; SECOND DEGREE RELATIVE; SUDDEN DEATH;

CARDIOMYOPATHY, HYPERTROPHIC; DNA; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; MUTATION;

EID: 53249093720     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2008.92     Document Type: Article

References (37)

1. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE: Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development in (young) adults. Circulation 1995; 92: 785-789.
2. Morita H, Larson MG, Barr SC et al: Single-gene mutations and increased left ventricular wall thickness in the community: The Framingham Heart Study. Circulation 2006; 113: 2697-2705.
3. Zou Y, Song L,Wang Z et al: Prevalence of idiopathic hypertrophic cardiomyopathy in China: A population-based echocardiographic analysis of 8080 adults. Am J Med 2004; 116: 14-18.
4. Maron BJ: Hypertrophic Aardiomyopathy: a systematic review. JAMA 2002; 287: 1308-1320.
5. Cannan CR, Reeder GS, Bailey KR, Melton III LJ, Gersh BJ: Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990. Circulation 1995; 92: 2488-2495.
6. Maron BJ, Olivotto I, Spirito P et al: Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population. Circulation 2000; 102 858-864.
7. de Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI et al: Out-of-hospital cardiac arrest in the 1990's: A population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997; 30: 1500-1505.
8. Girolami F, Olivotto I, Passerini I et al: A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy. J Cardiovasc Med (Hagerstown) 2006; 7: 601-607.
9. Richard P, Charron P, Carrier L et al: Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003; 107: 2227-2232.
10. Alders M, Jongbloed R, Deelen W et al: The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. Eur Heart J 2003; 24: 1848-1853.
11. Elliott PM, Poloniecki J, Dickie S et al: Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol 2000; 36: 2212-2218.
12. Elliott PM, Gimeno JR, Tome MT et al: Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 2006; 27: 1933-1941.
13. Kofflard MJ, Ten Cate FJ, van der Lee C, van Domburg RT: Hypertrophic cardiomyopathy in a large community-based population: Clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol 2003; 41: 987-993.
14. Niimura H, Bachinski LL, Sangwatanaroj S et al: Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998; 338: 1248-1257.
15. Maron BJ, McKenna WJ, Danielson GK et al: American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003; 42: 1687-1713.
16. Maron BJ, Estes III NA, Maron MS, Almquist AK, Link MS, Udelson JE: Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation 2003; 107: 2872-2875.
17. Maron BJ, Spirito P, Shen WK et al: Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007; 298: 405-412.
18. Marteau TM, Kinmonth AL: ScrePning for cardiovascular risk: public health imperative or matter for individual informed choice? BMJ 2002; 325: 78-80.
19. van Langen I, Hofman N, Tan HL, Wilde AA: Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Ann Med 2004; 36(Suppl 1): 116-124.
20. ASHG statement: Professional disclosure of familial genetic information. The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure. Am J Hum Genet 1998; 62: 474-483.
21. HeAmans J, Christiaans I, van Tintelen J, Wilde A, Pinto Y: GENCOR: a national registry for patients and families suffering from a familial heart disease in the Netherlands. Neth Heart J 2006; 14: 274-278.
22. Aktan-Collan K, Mecklin JP, Jarvinen H et al: Predictive genetic testing for hereditary non-polyposis colorectal cancer: Uptake and long-term satisfaction. Int J Cancer 2000; 89: 44-50.
23. Brooks L, Lennard F, Shenton A et al: BRCA 1/2 predictive testing: a study of uptake in two centres. Eur J Hum Genet 2004; 12: 654-662.
24. Codori AM, Petersen GM, Miglioretti DL et al: Attitudes toward colon cancer gene testing: Factors predicting test uptake. Cancer Epidemiol Biomarkers Prev 1999; 8: 345-351.
25. Lerman C, Hughes C, Trock BJ et al: Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 1999; 281: 1618-1622.
26. Suthers GK, Armstrong J, McCormack J, Trott D: Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet 2006; 43 665-670.
27. Hadley DW, Jenkins J, Dimond E et al: Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med 2003; 163: 573-582.
28. Kerzin-Storrar L, Wright C, Williamson PR et al: Comparison of genetic services with and without genetic registers: Access and attitudes to genetic counselling services among relatives of genetic clinic patients. J Med Genet 2002; 39: 85e.
29. Charron P, Heron D, Gargiulo M et al: Genetic testing and genetic counselling in hypertrophic cardiomyopathy: The French experience. J Med Genet 2002; 39: 741-746.
30. van Maarle MC, Stouthard ME, Marang-van de Mheen PJ, Klazinga NS, Bonsel GJ: How disturbing is it to be approached for a genetic cascade screening programme for familial hypercholesterolaemia? Psychological impact and screenees' views. Community Genet 2001; 4: 244-252.
31. Wright C, Kerzin-Storrar L, Williamson PR et al: Comparison of genetic services with and without genetic registers: Knowledge, adjustment, and attitudes about genetic counselling among probands referred to three genetic clinics. J Med Genet 2002; 39: 84e.
32. Andersen RM: Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 1995; 36: 1-10.
33. Biesecker BB, Ishibe N, Hadley DW et al: Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. Am J Med Genet 2000; 93: 257-263.
34. Foster C, Evans DG, Eeles R et al: Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort. Br J Cancer 2002; 86: 1209-1216.
35. Brain K, Sivell S, Bennert K et al: An exploratory comparison of genetic counselling protocols for HNPCC predictive testing. Clin Genet 2005; 68: 255-261.
36. Gaff CL, Clarke AJ, Atkinson P et al: Process and outcome in communication of genetic information within families: A systematic review. Eur J Hum Genet 2007; 15: 999-1011.
37. Newson AJ, Humphries SE: Cascade testing in familial hypercholesterolaemia: How should family members be contacted? Eur J Hum Genet 2005; 13: 401-408.